Sunday, June 18, 2006

Lobbying efforts over Angiomax patent extension

Legislation sought to overcome a patent application (patent extension) filing error by The Medicines Company concerning Angiomax is discussed in an article in the Boston Globe.

The Medicines Company expended $440,000 in lobbying efforts last year.


Post a Comment

<< Home